John A. Barranger

Medicine · Health Sciences

36h-index4.0kcitations107works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lysosomal Storage Disorders Research(73), Carbohydrate Chemistry and Synthesis(27), Glycosylation and Glycoproteins Research(26), Cellular transport and secretion(18), CRISPR and Genetic Engineering(9)

Publications107 total

Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014
American Journal of Hematology·2014· 8 cited
Evaluation of glycosphingolipid clearance in patients with Fabry disease treated with agalsidase alfa who switched to agalsidase beta (the INFORM study)
Molecular Genetics and Metabolism·2014
Lysosomal Disease Network’s “WORLD Symposium 2009”
Molecular Genetics and Metabolism·2008
An improved high-throughput dried blood spot screening method for Gaucher disease
Clinica Chimica Acta·2008· 41 cited
Prevalence of Type 1 Gaucher Disease in the United States
Archives of Internal Medicine·2008· 15 cited
Lysosomal Disease Network’s “WORLD Symposium 2008”
Molecular Genetics and Metabolism·2008
49. An improved dried blood spot screening method for Gaucher disease
Molecular Genetics and Metabolism·2008
46 A perspective on treatment and cures of Gaucher disease
Molecular Genetics and Metabolism·2007
Lysosomal Storage Disorders
2007· 28 cited
Gaucher Disease: Review and Perspectives on Treatment
2007
Lysosomal Storage Disorders: Gene Therapy
Encyclopedia of Life Sciences·2006· 3 cited
Guidance on the use of miglustat for treating patients with type 1 Gaucher disease
American Journal of Hematology·2005· 93 cited
Radiological Evidence of Early Cerebral Microvascular Disease in Young Children with Fabry Disease
The Journal of Pediatrics·2005· 40 cited
Correlation of surrogate markers of Gaucher disease. Implications for long-term follow up of enzyme replacement therapy
Clinica Chimica Acta·2004· 62 cited
Surrogate markers for lysosomal storage
Blood·2003· 1 citedOpen Access
Retrovirus-Mediated Gene Transfer to Human Hematopoietic Stem Cells
Humana Press eBooks·2003· 2 cited
Methods for Retrovirus-Mediated Gene Transfer to CD34<sup>+</sup>-Enriched Cells
Humana Press eBooks·2003
Demonstration of Feasibility of In Vivo Gene Therapy for Gaucher Disease Using a Chemically Induced Mouse Model
Molecular Therapy·2002· 53 citedOpen Access
Gene therapy for the lysosomal storage disorders.
PubMed·2002· 48 cited
Fabry Disease in Genetic Counseling Practice: Recommendations of the National Society of Genetic Counselors
Journal of Genetic Counseling·2002· 53 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

J. M. Tager(10), Gary J. Murray(9), Edward I. Ginns(8), Johannes M. F. G. Aerts(8), Roscoe O. Brady(7), Wilma E. Donker‐Koopman(5), Alfred B. Bahnson(4), André W. Schram(4), Mario A. Cabrera-Salazar(4), Prabhakara V. Choudary(3), Brian M. Martin(3), June A. Mayor(3), Paul D. Robbins(3), F S Furbish(3), Clifford J. Steer(3), Roscoe O. Brady(3), AndréW. Schram(3), Erin O’Rourke(3), Sonja van Weely(3), Shoji Tsuji(2)